Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China · Delayed Price · Currency is CNY 23.87
+0.30 (1.27%)
Nov 6, 2026, 3:00 PM CST
SHA:600285 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,952 | 3,853 | 3,501 | 3,311 | 3,002 | 2,694 |
Revenue Growth | 4.46% | 10.07% | 5.72% | 10.31% | 11.45% | 15.52% |
Gross Profit Gross Profit Growth | 3,098 | 3,081 | 2,652 | 2,423 | 2,164 | 1,986 |
Operating Income Operating Income Growth | 905.74 | 824.36 | 723.74 | 588.93 | 389.07 | 376.45 |
Net Income Net Income Growth | 827.37 | 759.5 | 722.55 | 568.11 | 465.3 | 361.54 |
Earnings Per Share EPS Growth | 1.46 | 1.34 | 1.28 | 1.00 | 0.82 | 0.64 |
EPS Growth | 4.02% | 4.45% | 27.72% | 22.47% | 28.37% | 11.34% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Offset of Business Segment Offset of Business Segment Growth | -21.85 |
Pharmaceutical and Healthcare Division Pharmaceutical and Healthcare Division Growth | 3,845 |
Others Others Growth | 29.92 |
Total Total Growth | 3,853 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,023 | 1,091 | 1,511 | 1,595 | 1,455 | 1,222 |
Total Debt Total Debt Growth | 322.33 | 416.38 | 98.8 | 207.99 | 158.57 | 281.89 |
Net Cash (Debt) Net Cash Growth | 700.52 | 674.41 | 1,413 | 1,387 | 1,296 | 940.31 |
Net Cash Growth | -16.04% | -52.26% | 1.86% | 6.96% | 37.88% | 41.69% |
Net Cash Per Share Net Cash Per Share Growth | 1.24 | 1.19 | 2.50 | 2.45 | 2.28 | 1.66 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,085 | 553.88 | 875.86 | 813.43 | 834.91 | 845.69 |
Capital Expenditures CapEx Growth | -59.66 | -56.83 | -115.11 | -21.2 | -26.99 | -76.91 |
Free Cash Flow Free Cash Flow Growth | 1,025 | 497.05 | 760.75 | 792.23 | 807.92 | 768.78 |
Free Cash Flow Growth | 14.35% | -34.66% | -3.97% | -1.94% | 5.09% | 103.00% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 78.39% | 79.96% | 75.77% | 73.17% | 72.10% | 73.72% |
Operating Margin | 22.92% | 21.39% | 20.67% | 17.78% | 12.96% | 13.98% |
Pretax Margin | 24.32% | 22.82% | 23.64% | 19.72% | 17.22% | 15.35% |
Profit Margin | 20.94% | 19.71% | 20.64% | 17.16% | 15.50% | 13.42% |
FCF Margin | 25.94% | 12.90% | 21.73% | 23.92% | 26.91% | 28.54% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.100 | 1.100 | 0.900 | 0.800 | 0.600 | 0.500 |
Dividend Per Share Growth | 22.22% | 22.22% | 12.50% | 33.33% | 20.00% | 25.00% |
Dividend Yield | 4.61% | 5.34% | 4.07% | 4.68% | 4.64% | 3.16% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.36 | 15.36 | 17.27 | 16.98 | 15.81 | 24.67 |
Forward PE | 16.34 | 13.59 | 16.50 | 16.45 | 14.45 | 20.52 |
P/FCF Ratio | 13.21 | 23.47 | 16.40 | 12.18 | 9.11 | 11.60 |
PS Ratio | 3.43 | 3.03 | 3.57 | 2.91 | 2.45 | 3.31 |